Simplified Papilla Preservation Flap(SPPF) and Enamel Matrix Derivative(EMD) With or Without Connective Tissue(CTG) Wall for the Treatment of Non Contained Infrabony Defects. A Randomized Controlled Clinical Trail
NCT ID: NCT06530199
Last Updated: 2024-07-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
30 participants
INTERVENTIONAL
2024-07-31
2025-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
control group
Simplified papilla preservation flap with enamel matrix derivative will be performed
Enamel matrix derivative
connective tissue graft and Enamel matrix derivative in the defect area
Test group
Simplified papilla preservation flap with connective tissue graft and enamel matrix derivative will be performed
Enamel matrix derivative
connective tissue graft and Enamel matrix derivative in the defect area
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Enamel matrix derivative
connective tissue graft and Enamel matrix derivative in the defect area
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants aged ≥18 years to 55 years.
* Presented with non contained infra bony defects.
* Presence of at least 1 non contained infra bony defect(IBD) with a pocket probing depth ≥6mm after reevaluation of the hygienic phase and a depth of IBD ≥3mm as detected on radiographs, with radiographic angulation of ≥37⸰ , and exhibiting a 1 or 2 wall infra bony defect15(assessed by a bone sounding and confirmed intrasurgically)
* Patient's full mouth plaque score and bleeding score \<20% at the time of surgical procedure.
* No history of periodontal surgery at the experimental site.
Exclusion Criteria
* Pregnant and lactating females.
* History of tobacco smoking .
* Patients with systemic disease.
* Known allergy or hypersensitivity to EMD.
* Presence of pulpal and peri apical involvement
18 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Krishnadevaraya College of Dental Sciences & Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Head of the department and professor
Role: CONTACT
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
02_D012_147502
Identifier Type: -
Identifier Source: org_study_id